TickerFacts.

Aytu Biopharma, Inc (AYTU): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

$3.25M
Year ended 2026-06-30
2014-06-30: -$5.51M2015-06-30: -$6.63M2016-06-30: -$10.91M2017-06-30: -$13.94M2018-06-30: -$16.02M2019-06-30: -$13.89M2020-06-30: -$28.37M2024-06-30: -$1.72M2025-06-30: -$2.17M2026-06-30: $3.25M$3.25M
2014-06-30 Free Cash Flow (USD) 2026-06-30
Period endedFree Cash FlowChange YoYSource filing
2026-06-30$3.25Mn/m2026-09-22, From 2025-07-01
2025-06-30-$2.17Mn/m2026-09-22, From 2024-07-01
2024-06-30-$1.72Mn/a2025-09-23, From 2023-07-01
No annual figure between 2020-06-30 and 2024-06-30.
2020-06-30-$28.37Mn/m2021-09-28, From 2019-07-01
2019-06-30-$13.89Mn/m2020-10-06, From 2018-07-01
2018-06-30-$16.02Mn/m2019-09-26, From 2017-07-01
2017-06-30-$13.94Mn/m2018-09-06, From 2016-07-01
2016-06-30-$10.91Mn/m2017-08-31, From 2015-07-01
2015-06-30-$6.63Mn/m2016-09-01, From 2014-07-01
2014-06-30-$5.51Mn/a2015-09-28, From 2013-07-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Aytu Biopharma, Inc (AYTU)2026-06-30$3.25Mn/m
Nektar Therapeutics (NKTR)2025-12-31-$208.68Mn/m
Integrated Biopharma Inc (INBP)2025-06-30$1.87M+380.5%
Agios Pharmaceuticals, Inc. (AGIO)2025-12-31-$377.29Mn/m
Q32 Bio Inc. (QTTB)2025-12-31-$33.54Mn/m
Tango Therapeutics, Inc. (TNGX)2025-12-31-$139.93Mn/m
Ocular Therapeutix, Inc (OCUL)2025-12-31-$216.89Mn/m
Enanta Pharmaceuticals Inc (ENTA)2025-09-30-$32.17Mn/m
Lexicon Pharmaceuticals, Inc. (LXRX)2025-12-31-$67.85Mn/m

Compare AYTU, NKTR, INBP, AGIO side by side · Screen every company in Pharmaceutical Preparations ↗